Dirk Föll

435 total citations
12 papers, 248 citations indexed

About

Dirk Föll is a scholar working on Speech and Hearing, Hematology and Molecular Biology. According to data from OpenAlex, Dirk Föll has authored 12 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Speech and Hearing, 6 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Dirk Föll's work include Adolescent and Pediatric Healthcare (6 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Immune Cell Function and Interaction (2 papers). Dirk Föll is often cited by papers focused on Adolescent and Pediatric Healthcare (6 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Immune Cell Function and Interaction (2 papers). Dirk Föll collaborates with scholars based in Germany, United Kingdom and Latvia. Dirk Föll's co-authors include Kirsten Minden, Arnd Heiligenhaus, Uwe Pleyer, Gerd Horneff, Norbert Wagner, Jens Klotsche, Claudia Sengler, Ina Liedmann, Gerd Ganser and Johannes‐Peter Haas and has published in prestigious journals such as Lara D. Veeken, International Immunopharmacology and Shock.

In The Last Decade

Dirk Föll

11 papers receiving 241 citations

Peers

Dirk Föll

HEMAT

IMMUN

RHEUM

MB

OPHTH

Andrew Lasky United States

Tova Ronis United States

Perrine Dusser France

G. Elizabeth Legger Netherlands

I. Rumba Sweden

Laura Smith United States

Andreas Woerner Switzerland

Seyed Reza Raeeskarami Iran

J Barrier France

Elif İnce Türkiye

Andrew Lasky United States

Dirk Föll

138 ×1.2

HEMAT

22 ×0.3

IMMUN

100 ×1.6

RHEUM

23 ×0.4

MB

70 ×1.4

OPHTH

Citations per year, relative to Dirk Föll Dirk Föll (= 1×) peers Andrew Lasky

Countries citing papers authored by Dirk Föll

Since Specialization

Citations

This map shows the geographic impact of Dirk Föll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Föll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Föll more than expected).

Fields of papers citing papers by Dirk Föll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Föll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Föll. The network helps show where Dirk Föll may publish in the future.

Co-authorship network of co-authors of Dirk Föll

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Föll. A scholar is included among the top collaborators of Dirk Föll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Föll. Dirk Föll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Horneff, Gerd, et al.. (2022). Pro-Kind Rheuma – aktueller Stand des GBA-Projektes. Aktuelle Rheumatologie. 47(2). 110–116.

2.

Regel, Andrea, Dirk Föll, & Martin Kriegel. (2021). Morbus Still – Ähnlichkeiten und Differenzen zwischen juveniler und adulter Form. Zeitschrift für Rheumatologie. 81(1). 22–27. 2 indexed citations

3.

Wagner, Norbert, Gabriele Arendt, Erika Baum, et al.. (2019). Impfen bei Immundefizienz. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 62(4). 494–515. 71 indexed citations

4.

Klein, Ariane, Jens Klotsche, Boris Hügle, et al.. (2019). Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry. Lara D. Veeken. 59(9). 2287–2298. 22 indexed citations

5.

Ohl, Kim, Halima Moncrieffe, Dirk Föll, et al.. (2018). The transcription factor CREM drives an inflammatory phenotype of T cells in oligoarticular juvenile idiopathic arthritis. Pediatric Rheumatology. 16(1). 39–39. 21 indexed citations

6.

Tenbrock, Klaus, Dirk Föll, Kirsten Minden, Jens Klotsche, & Gerd Horneff. (2018). Nachrichten der Gesellschaft für Kinder- und Jugendrheumatologie. Arthritis und Rheuma. 38(5). 368–368. 1 indexed citations

7.

Tenbrock, Klaus, Dirk Föll, Kirsten Minden, Jens Klotsche, & Gerd Horneff. (2018). Handlungs- und Therapie- Protokolle in der Kinder-Rheumatologie. Kinder- und Jugendmedizin. 18(5). 350–350. 1 indexed citations

8.

Wittkowski, Helmut, Aristotelis Antonopoulos, Stuart M. Haslam, et al.. (2017). Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib. International Immunopharmacology. 44. 216–225. 6 indexed citations

9.

Heiligenhaus, Arnd, Kirsten Minden, Dirk Föll, & Uwe Pleyer. (2015). Uveitis in Juvenile Idiopathic Arthritis. Deutsches Ärzteblatt international. 112(6). 92–100, i. 48 indexed citations

10.

Sengler, Claudia, Jens Klotsche, Martina Niewerth, et al.. (2015). The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort. RMD Open. 1(1). e000074–e000074. 47 indexed citations

11.

Cypers, Heleen, Gaëlle Varkas, Liesbet Van Praet, et al.. (2014). Calgranulin levels are elevated in spondyloarthritis and reflect the presence of acute microscopic gut inflammation. Ghent University Academic Bibliography (Ghent University). 66. 1 indexed citations

12.

Achouiti, Ahmed, Dirk Föll, Thomas Vogl, et al.. (2013). S100A12 and Soluble Receptor for Advanced Glycation End Products Levels During Human Severe Sepsis. Shock. 40(3). 188–194. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact